Annals of Medicine and Medical Sciences
Clinical Outcomes of Next-Generation Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia
Objective: To evaluate efficacy, durability, and safety of next-generation chimeric antigen receptor T-cell therapies in relapsed or refractory acute lymphoblas…
By Dr. Birupaksha Biswas, MD | Feb 1, 2026
Feb 1, 2026